Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia
Abstract Schizophrenia (SZ) is a deleterious brain disorder characterised by its heterogeneity and complex symptomatology consisting of positive, negative and cognitive deficits. Current antipsychotic drugs ameliorate the positive symptomatology, but are inefficient in treating the negative symptoma...
Saved in:
Main Authors: | David Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, Sergi Mas, Constanza Morén, Eduard Parellada, Patricia Gassó |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-024-03194-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
by: Fabrizio Gasparini, et al.
Published: (2013-01-01) -
Sustained Activity of Metabotropic Glutamate Receptor: Homer, Arrestin, and Beyond
by: Geehoon Chung, et al.
Published: (2017-01-01) -
Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease
by: Hugh Chan, et al.
Published: (2010-01-01) -
Common Mechanisms Underlying Opioid Tolerance and Dependence and Neuropathic Pain: Role of Metabotropic Glutamate Receptors
by: Marian E Fundytus
Published: (2000-01-01) -
Mapping hippocampal glutamate in healthy aging with in vivo glutamate-weighted CEST (GluCEST) imaging
by: Maggie K. Pecsok, et al.
Published: (2025-01-01)